Taurolithocholic acid-3 sulfate induces CD95 trafficking and apoptosis in a c-Jun N-terminal kinase-dependent manner

Gastroenterology

Volumn 122, Issue 5, 2002, Pages 1411-1427

  Graf, Dirk ^a   Kurz, Anna Kordelia ^a   Fischer, Richard ^a   Reinehr, Roland ^a   Häussinger, Dieter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BILE ACID; CASPASE 3; CASPASE 8; CASPASE 9; CHOLERETIC AGENT; FAS ANTIGEN; LIPOCORTIN 5; MITOGEN ACTIVATED PROTEIN KINASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TAUROLITHOCHOLIC ACID; TAUROLITHOCHOLIC ACID 3 SULFATE; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; ARTICLE; BILE FLOW; CELL MEMBRANE TRANSPORT; CHOLESTASIS; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVATION; ENZYME ASSAY; HYDROPHOBICITY; IN VITRO STUDY; LIVER CELL; LIVER CELL DAMAGE; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; RAT; WESTERN BLOTTING;

EID: 0036241214     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.32976     Document Type: Article

References (59)

1. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of CD95
2. Bile salt-induced apoptosis of hepatocytes involves activation of protein kinase C
3. Hepatocyte apoptosis after bile duct ligation in the mouse involves CD95
4. Increases of intracellular magnesium promote glycodeoxycholate-induced apoptosis in rat hepatocytes
5. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition
6. The bile acid-activated phosphatidylinositol 3-kinase pathway inhibits CD95 apoptosis upstream of bid in rodent hepatocytes
7. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes
8. Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes
9. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation
10. Apoptosis induced in rat hepatocytes by in vivo exposure to taurochenodeoxycholate
11. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of CD95
12. Cathepsin B contributes to bile salt-induced apoptosis of rat hepatocytes
13. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production
14. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation
15. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids
16. Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: A placebo-controlled trial
17. Ursodeoxycholic acid in primary biliary cirrhosis: Results of a controlled double-blind trial
18. Ursodeoxycholic acid therapy of chronic cholestatic conditions in adults and children
19. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis
20. Ursodiol for hepatobiliary disorders
21. Tauroursodeoxycholate-induced choleresis involves dual MAP kinase activation and translocation of the bile salt export pump (Bsep) to the canalicular membrane
22. Tauroursodeoxycholate prevents taurocholate induced cholestasis
23. Cell volume and bile acid excretion
24. Involvement of microtubules in the swelling-induced stimulation of transcellular taurocholate transport in perfused rat liver
25. Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes
26. Mitogen-activated protein kinases mediate the stimulation of bile acid secretion by tauroursodeoxycholate in rat liver
27. Phosphoinositide 3-kinase-dependent Ras activation by tauroursodeoxycholate in rat liver
28. Tauroursodeoxycholate and S-adenosyl-L-methionine exert an additive ameliorating effect on taurolithocholate-induced cholestasis: A study in isolated rat hepatocyte couplets
29. Cyclic adenosine monophosphate-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes
30. Deoxycholic acid (dca) causes ligand-independent activation of epidermal growth factor receptor (egfr) and fas receptor in primary hepatocytes: Inhibition of egfr/mitogen-activated protein kinase-signaling module enhances dca-induced apoptosis
31. Activation and role of mitogen-activated protein kinases in deoxycholic acid-induced apoptosis
32. Phosphoinositide 3-kinase, but not mitogen-activated protein kinase, pathway is involved in hepatocyte growth factor-mediated protection against bile acid-induced apoptosis in cultured rat hepatocytes
33. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade
34. Lithocholate metabolism during chemotherapy for gallstone dissolution
35. Bile acids and their sulphated and glucuronidated derivatives in bile, plasma and urine of children with intrahepatic cholestasis; effects of phenobarbital treatment
36. + taurocholate cotransport and its encoding mRNA in primary cultures of rat hepatocytes
37. Akt/PKB and other D3 phosphoinositide regulated kinases: Kinase activation by phosphoinositide-dependent phosphorylation
38. Bcl-2 family members and the mitochondria in apoptosis
39. The death domain kinase RIP is essential for TRAIL (Apo2L)-induced activation of IKB kinase and c-Jun N-terminal kinase
40. CD95 triggers an alternative, caspase 8-independent cell death pathway using the RIP kinase as effector molecule
41. Activation of a proapoptotic amplification loop through inhibition of NF-kappaB-dependent survival signals by caspase-mediated inactivation of RIP
42. The death domain kinase RIP mediates TNF-induced NF-kappaB signal
43. Tumor necrosis factor signaling to stress-activated protein kinase (SAPK/Jun NH2-terminal kinase, JNK) and p38
44. Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP) and blockage of tumor necrosis factor-induced nuclear factor NF-κB activation
45. Selective inhibition of protein kinase C ioenzymes by the indolocarbazole Gö6976
46. Cell-permeable peptide inhibitors of JNK. Novel blockers of beta-cell death
47. Two CD95 (APO-1/Fas) signaling pathways
48. Vitamin E reduces oxidant injury to mitochondria and the hepatotocity of taurochenodeoxycholic acid in the rat
49. C-Jun NH2-terminal kinase activation leads to a FADD-dependent but CD95 ligand-independent cell death in Jurkat T cells
50. Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis
51. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation
52. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells
53. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
54. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation
55. Effects of bile salts on the plasma membranes of isolated rat hepatocytes
56. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat
57. The mitochondrial permeability transition in cell death: A common mechanism in necrosis, apoptosis and autophagy
58. Toxicity of bile acids on the electron transport chain of isolated liver mitochondria
59. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1